- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, September 27, 2024
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article from Becker’s ASC Review referenced a study published in the April 2024 issue of The American Journal of Managed Care® (AJMC®). The study, “Prices and Complications in Hospital-Based and Freestanding Surgery Centers,” found that higher prices for procedures performed in hospital outpatient departments did not indicate better quality compared with procedures performed in nonhospital ambulatory surgery centers.
A report released by the National Association of ACOs cited 2 studies published in AJMC. The first, “Changes in Specialty Care Use and Leakage in Medicare Accountable Care Organizations,” was published in the May 2018 issue and found that leakage of specialty care changed minimally in the Medicare Shared Savings Program. The second, “Accountable Care Organization Initiatives to Improve the Cost and Outcomes of Specialty Care,” was released in the May 2024 issue and found that engaging specialists in accountable care has numerous challenges and represents an emerging area for accountable care organizations.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Radiation Bridging Therapy Boosts CAR T Outcomes in R/R LBCL
April 3rd 2025In this comparative analysis, patients with relapsed/refractory large B-cell lymphoma (R/R LBCL) received bridging therapy via radiation or systemic treatment while their chimeric antigen receptor T-cell therapy (CAR T) was being manufactured.
Read More
